A Rationale for Hormone Replacement Therapy in Organ Transplant Patients

  • Marie L. Foegh
Part of the Medical Science Symposia Series book series (MSSS, volume 13)


Estrogens are steroid hormones that have important roles in the cardiovascular system and in maintenance of bone tissue. These effects are mediated by a ligand-activated transcription factor, the estrogen receptor (ER) [1]. Clinically the question arises as to whether estrogen replacement therapy (ERT) is indicated in postmenopausal recipients of organ transplants. Post-transplantation hypertension, hyperlipidemia, and insulin dependent diabetes develop in the immunosuppressed recipient. Renal transplant patients are already at high risk for cardiovascular complications of atherosclerosis and many patients have severe osteoporosis at the time they receive a renal allograft. The well-known female advantage in cardiovascular disease prior to menopause appears to be abrogated in transplant recipients. The female origin of the allograft appears to be a risk factor. The reason for the difference in risk of atherosclerosis/arteriosclerosis in the female organ in its natural host compared to in the transplant host is most likely of immune origin and is most spectacularly seen in the coronary arteries of the cardiac allograft. This graft arteriosclerosis presents as a characteristic vasculopathy consisting of a continous concentric myointimal thickening which is universal in all solid organ allografts and limits long-term graft and patient survival.


Estrogen Receptor Estrogen Replacement Therapy Cardiac Allograft Balloon Injury Aorta Allograft 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Foegh ML, Ramwell PW. Cardiovascular effects of estrogen — Implications of the discovery of the estrogen receptor subtype ERβ. Current Opinion in Nephrol Hypertension 1998;7:83–9.CrossRefGoogle Scholar
  2. 2.
    Foegh ML, Ramwell PW. Pharmacologic control of smooth muscle cells in allografts. Transplant Immunol 1997;5:267–75.CrossRefGoogle Scholar
  3. 3.
    Foegh M, Rego A, Lou H, Katz N, Ramwell P. Gender effects on graft myointimal hyperplasia. Transpl Proc 1995;27:2070–73.Google Scholar
  4. 4.
    White CR, Shelton J, Chen S-J, et al. Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation 1997;96:1624–30.PubMedGoogle Scholar
  5. 5.
    Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994;19:722–26.PubMedGoogle Scholar
  6. 6.
    Kuiper G, Enmark E, Pelto-Huiko M, Nielsson S, Gustafsson J-Å. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci, USA 1996;93:5925–30.PubMedCrossRefGoogle Scholar
  7. 7.
    Iafrati MD, Karas RH, Aronovitz M, et al. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nature Med 1997;3:545–48.PubMedCrossRefGoogle Scholar
  8. 8.
    Enmark E, Pelto-Huiko M, Grandien K, et al. Human estrogen receptor β-gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab 1997;82:4258–65.PubMedCrossRefGoogle Scholar
  9. 9.
    Lou H, Martin MB, Stoica A, Ramwell PW, Foegh ML. Upregulation of estrogen receptor-α expression in cardiac allograft. Circ Res In press.Google Scholar
  10. 10.
    Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocrine Rev 1996;17:369–84.CrossRefGoogle Scholar
  11. 11.
    Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transpl Proc 1987;19:90–94.Google Scholar
  12. 12.
    Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation 1991;52:967–72PubMedCrossRefGoogle Scholar
  13. 13.
    Lou H, Kodama T, Maurice P, Wang YN, Katz NM, Foegh ML. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolishing MHC class II antigen expression. Circulation 1996;94:3355–61.PubMedGoogle Scholar
  14. 14.
    Saito S, Foegh ML, Motomura N, Lou H, Kent K, Ramwell PW. Estradiol inhibits allograft inducible major histocompatibility MHC-class II antigen expression and transplant arteriosclerosis in the absence of immuno-suppression. Transplantation In press.Google Scholar
  15. 15.
    Foegh ML, Ramwell PW. The protective effect of estradiol in transplant arteriosclerosis. In: Rabuanyi G, Kauffman R, editors. Estrogens and the vessel wall. Amsterdam: Harwood Academic Publishers, 1998:213–24.Google Scholar
  16. 16.
    Motomura N, Lou H, Hong M, Tsutsumi Y, Mayumi T, Foegh ML. Local administration of estrogen inhibits transplant arteriosclerosis in rat aorta accelerated by topical exposure to IGF-I. Transpl Proc 1997;29:1118–20.CrossRefGoogle Scholar
  17. 17.
    Lou H, Zhao Y, Delafontaine P, et al. Estrogen effects on insulin-like growth factor-I (IGF-I) induced cell proliferation and IGF-I expression in native and allograft vessels. Circulation. 1997;96:927–33.PubMedGoogle Scholar
  18. 18.
    Saito S, Motomura N, Lou H, Ramwell PW, Foegh ML. Specific effects of estrogen on growth factor and MHC class II expression in rat aorta allograft. J Thorac Cardiovasc Surg 1997;114:803–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Marino IR, Doyle HR, Aldringhetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995;22:1754–62.PubMedGoogle Scholar
  20. 20.
    Velosa JA, Offord KP, Schroeder DR. Effect of age, sex and glomerular filtration on renal function outcome of living kidney donors. Transplantation 1995, 60:1618–21.PubMedGoogle Scholar
  21. 21.
    Boucek MM, Novick RJ, Bennett LF, Fiol B, Keck BM, Hosenpud JD. The registry of the International Society of Heart and Lung Transplantation: First official pediatric report-1997. J Heart Lung Transplant 1997;16:1189–206.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers and Fondazione Giovanni Lorenzini 1999

Authors and Affiliations

  • Marie L. Foegh

There are no affiliations available

Personalised recommendations